These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11788479)

  • 1. Stromal cells are the main plasminogen activator inhibitor-1-producing cells in human fat: evidence of differences between visceral and subcutaneous deposits.
    Bastelica D; Morange P; Berthet B; Borghi H; Lacroix O; Grino M; Juhan-Vague I; Alessi MC
    Arterioscler Thromb Vasc Biol; 2002 Jan; 22(1):173-8. PubMed ID: 11788479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease.
    Alessi MC; Peiretti F; Morange P; Henry M; Nalbone G; Juhan-Vague I
    Diabetes; 1997 May; 46(5):860-7. PubMed ID: 9133556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosiglitazone inhibits the insulin-mediated increase in PAI-1 secretion in human abdominal subcutaneous adipocytes.
    Harte AL; McTernan PG; McTernan CL; Smith SA; Barnett AH; Kumar S
    Diabetes Obes Metab; 2003 Sep; 5(5):302-10. PubMed ID: 12940867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory cytokines interleukin-6 and oncostatin m induce plasminogen activator inhibitor-1 in human adipose tissue.
    Rega G; Kaun C; Weiss TW; Demyanets S; Zorn G; Kastl SP; Steiner S; Seidinger D; Kopp CW; Frey M; Roehle R; Maurer G; Huber K; Wojta J
    Circulation; 2005 Apr; 111(15):1938-45. PubMed ID: 15837947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasminogen activator inhibitor type 1 (PAI-1) in plasma and adipose tissue in HIV-associated lipodystrophy syndrome. Implications of adipokines.
    He G; Andersen O; Haugaard SB; Lihn AS; Pedersen SB; Madsbad S; Richelsen B
    Eur J Clin Invest; 2005 Sep; 35(9):583-90. PubMed ID: 16128865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity.
    Alessi MC; Bastelica D; Morange P; Berthet B; Leduc I; Verdier M; Geel O; Juhan-Vague I
    Diabetes; 2000 Aug; 49(8):1374-80. PubMed ID: 10923640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in plasminogen activator inhibitor 1 in subcutaneous versus omental adipose tissue in non-obese and obese subjects.
    He G; Pedersen SB; Bruun JM; Lihn AS; Jensen PF; Richelsen B
    Horm Metab Res; 2003 Mar; 35(3):178-82. PubMed ID: 12734779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoids and insulin promote plasminogen activator inhibitor 1 production by human adipose tissue.
    Morange PE; Aubert J; Peiretti F; Lijnen HR; Vague P; Verdier M; Négrel R; Juhan-Vague I; Alessi MC
    Diabetes; 1999 Apr; 48(4):890-5. PubMed ID: 10102708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similar PAI-1 expression in visceral and subcutaneous fat of postmenopausal women.
    Polac I; Cierniewska-Cieslak A; Stachowiak G; Pertynski T; Cierniewski CS
    Thromb Res; 2001 Jun; 102(5):397-405. PubMed ID: 11395125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional variation in plasminogen activator inhibitor-1 expression in adipose tissue from obese individuals.
    Eriksson P; Van Harmelen V; Hoffstedt J; Lundquist P; Vidal H; Stemme V; Hamsten A; Arner P; Reynisdottir S
    Thromb Haemost; 2000 Apr; 83(4):545-8. PubMed ID: 10780314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue distribution and regulation of plasminogen activator inhibitor-1 in obese mice.
    Samad F; Loskutoff DJ
    Mol Med; 1996 Sep; 2(5):568-82. PubMed ID: 8898373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fat depot-related differences in gene expression, adiponectin secretion, and insulin action and signalling in human adipocytes differentiated in vitro from precursor stromal cells.
    Perrini S; Laviola L; Cignarelli A; Melchiorre M; De Stefano F; Caccioppoli C; Natalicchio A; Orlando MR; Garruti G; De Fazio M; Catalano G; Memeo V; Giorgino R; Giorgino F
    Diabetologia; 2008 Jan; 51(1):155-64. PubMed ID: 17960360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of PAI-1 on adipose tissue growth and metabolic parameters in a murine model of diet-induced obesity.
    Morange PE; Lijnen HR; Alessi MC; Kopp F; Collen D; Juhan-Vague I
    Arterioscler Thromb Vasc Biol; 2000 Apr; 20(4):1150-4. PubMed ID: 10764686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and secretion of plasminogen activator inhibitor-1 by human preadipocytes.
    Crandall DL; Quinet EM; Morgan GA; Busler DE; McHendry-Rinde B; Kral JG
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3222-7. PubMed ID: 10487691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of cytokines in the regulation of plasminogen activator inhibitor-1 expression and secretion in newly differentiated subcutaneous human adipocytes.
    Birgel M; Gottschling-Zeller H; Röhrig K; Hauner H
    Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1682-7. PubMed ID: 10845889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activator inhibitor-1 modulates adipocyte differentiation.
    Liang X; Kanjanabuch T; Mao SL; Hao CM; Tang YW; Declerck PJ; Hasty AH; Wasserman DH; Fogo AB; Ma LJ
    Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E103-E113. PubMed ID: 16144810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individuals.
    Eriksson P; Reynisdottir S; Lönnqvist F; Stemme V; Hamsten A; Arner P
    Diabetologia; 1998 Jan; 41(1):65-71. PubMed ID: 9498632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tumor necrosis factor alpha and transforming growth factor beta 1 on plasminogen activator inhibitor-1 secretion from subcutaneous and omental human fat cells in suspension culture.
    Gottschling-Zeller H; Birgel M; Röhrig K; Hauner H
    Metabolism; 2000 May; 49(5):666-71. PubMed ID: 10831181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss.
    Mavri A; Alessi MC; Bastelica D; Geel-Georgelin O; Fina F; Sentocnik JT; Stegnar M; Juhan-Vague I
    Diabetologia; 2001 Nov; 44(11):2025-31. PubMed ID: 11719834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated expression of transforming growth factor-beta in adipose tissue from obese mice.
    Samad F; Yamamoto K; Pandey M; Loskutoff DJ
    Mol Med; 1997 Jan; 3(1):37-48. PubMed ID: 9132278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.